Recent News

• 03.27.2026 - Crinetics Pharmaceuticals Solicita Autorização de Comercialização de Palsonify™ (Paltusotina) no Brasil para Tratamento de Acromegalia
• 03.26.2026 - Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly
• 02.26.2026 - Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Recent Filings

• 03.26.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.23.2026 - 8-K Current report
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 144 Report of proposed sale of securities
• 03.16.2026 - 144 Report of proposed sale of securities
• 03.16.2026 - 144 Report of proposed sale of securities
• 03.16.2026 - 144 Report of proposed sale of securities
• 03.13.2026 - 4 Statement of changes in beneficial ownership of securities